Literature DB >> 23681277

[Nutrition and liver failure].

M Plauth1.   

Abstract

In the critically ill liver patient, nutrition support is not very different from that given for other illnesses. In hyperacute liver failure, nutrition support is of less importance than in the other subtypes of acute liver failure that take a more protracted course. Nasoenteral tube feeding using a polymeric standard formula should be the first-line approach, while parenteral nutrition giving glucose, fat, amino acids, vitamins, and trace elements is initiated when enteral nutrition is insufficient or impracticable. In chronic liver disease, notably cirrhosis, there is frequently protein malnutrition indicating a poor prognosis and requiring immediate initiation of nutrition support. Enteral nutrition ensuring an adequate provision of energy and protein should be preferred. Particular care should be taken to avoid refeeding syndrome and to treat vitamin and trace element deficiency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681277     DOI: 10.1007/s00063-012-0200-4

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  43 in total

Review 1.  [Guidelines of GASL for nutrition in liver diseases and liver transplantation].

Authors:  M Plauth; A Weimann; E Holm; M J Müller
Journal:  Z Gastroenterol       Date:  1999-04       Impact factor: 2.000

2.  ESPEN Guidelines on Parenteral Nutrition: hepatology.

Authors:  Mathias Plauth; Eduard Cabré; Bernard Campillo; Jens Kondrup; Giulio Marchesini; Tatjana Schütz; Alan Shenkin; Julia Wendon
Journal:  Clin Nutr       Date:  2009-06-11       Impact factor: 7.324

3.  Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin molecule.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; C L van Berlo; P B Soeters
Journal:  Med Hypotheses       Date:  1999-06       Impact factor: 1.538

4.  Accelerated improvement of alcoholic liver disease with enteral nutrition.

Authors:  P J Kearns; H Young; G Garcia; T Blaschke; G O'Hanlon; M Rinki; K Sucher; P Gregory
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

5.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

6.  Energy expenditure in acetaminophen-induced fulminant hepatic failure.

Authors:  T S Walsh; S J Wigmore; P Hopton; R Richardson; A Lee
Journal:  Crit Care Med       Date:  2000-03       Impact factor: 7.598

Review 7.  Acute-on chronic liver failure.

Authors:  Rajiv Jalan; Pere Gines; Jody C Olson; Rajeshwar P Mookerjee; Richard Moreau; Guadalupe Garcia-Tsao; Vicente Arroyo; Patrick S Kamath
Journal:  J Hepatol       Date:  2012-06-28       Impact factor: 25.083

8.  Clinical practice of nutrition in acute liver failure--a European survey.

Authors:  Tatjana Schütz; Wolf-Otto Bechstein; Peter Neuhaus; Herbert Lochs; Mathias Plauth
Journal:  Clin Nutr       Date:  2004-10       Impact factor: 7.324

9.  Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy.

Authors:  P P Keohane; H Attrill; G Grimble; R Spiller; P Frost; D B Silk
Journal:  JPEN J Parenter Enteral Nutr       Date:  1983 Jul-Aug       Impact factor: 4.016

10.  Energy metabolism in acute hepatic failure.

Authors:  B Schneeweiss; J Pammer; K Ratheiser; B Schneider; C Madl; L Kramer; A Kranz; P Ferenci; W Druml; G Grimm
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

View more
  2 in total

Review 1.  [Management of decompensated liver cirrhosis in the intensive care unit].

Authors:  O Lerschmacher; A Koch; K Streetz; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-14       Impact factor: 0.840

Review 2.  [Treatment strategies for acute-on-chronic liver failure].

Authors:  A-R Kabbani; T L Tergast; M P Manns; B Maasoumy
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.